An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3α-HSD, type 5 17β-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent malignancies-Reference-Cited by-同舟云学术

An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3α-HSD, type 5 17β-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent malignancies

Published:2008-01 Issue:2 Volume:75 Page:484-493
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Byrns Michael C.,Steckelbroeck Stephan,Penning Trevor M.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference50 articles.

1. Cancer facts and figures 2005;American Cancer Society,2005

2. Drug insight: role of the androgen receptor in the development and progression of prostate cancer;Taplin;Nat Clin Pract Oncol,2007

3. Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors;Goss;Drugs,2002

4. Aldo-keto reductase (AKR) 1C3: role in prostate disease and the development of specific inhibitors;Penning;Mol Cell Endocrinol,2006

5. Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1–AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones;Penning;Biochem J,2000

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Involvement of porcine and human carbonyl reductases in the metabolism of epiandrosterone, 11-oxygenated steroids, neurosteroids, and corticosteroids;The Journal of Steroid Biochemistry and Molecular Biology;2024-10

2. Analysis of Expression and Regulation of AKR1C2 in HPV-Positive and -Negative Oropharyngeal Squamous Cell Carcinoma;Cancers;2024-08-27

3. Indomethacin Derivatives as Potential Anticancer Agents ‐ Daybreak of New Epoch;ChemistrySelect;2024-08-08

4. Catalytic characteristics of AKR1C1-AKR1C4 and AKR1C9 on oxymesterone;Molecular Catalysis;2024-06

5. AKR1C3 in carcinomas: from multifaceted roles to therapeutic strategies;Frontiers in Pharmacology;2024-03-08